{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=phenylephrine+solution", "query": { "intervention": "phenylephrine solution" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 47, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=phenylephrine+solution&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T10:27:32.330Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01058746", "title": "Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "restrictive perioperative fluid management", "type": "OTHER" }, { "name": "Liberal perioperative fluid management", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 331, "start_date": "2010-01", "completion_date": "2019-09", "has_results": false, "last_update_posted_date": "2019-09-25", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01058746" }, { "nct_id": "NCT02132312", "title": "A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Unilateral Cataract Extraction", "Congenital Cataract" ], "interventions": [ { "name": "OMS302", "type": "DRUG" }, { "name": "Phenylephrine HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Omeros Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "47 Months", "sex": "ALL", "summary": "1 Day to 47 Months" }, "enrollment_count": 78, "start_date": "2014-07", "completion_date": "2016-09-12", "has_results": true, "last_update_posted_date": "2021-07-22", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 11, "location_summary": "Los Angeles, California • Atlanta, Georgia • Chicago, Illinois + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02132312" }, { "nct_id": "NCT02946125", "title": "Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mydriasis" ], "interventions": [ { "name": "MDD-administered EYN-1601", "type": "COMBINATION_PRODUCT" }, { "name": "Phenylephrine 2.5% Eyedrop", "type": "DRUG" }, { "name": "Phenylephrine 10% Eyedrop", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "Eyenovia Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2016-10", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2022-07-27", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Artesia, California", "locations": [ { "city": "Artesia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02946125" }, { "nct_id": "NCT03592121", "title": "Study to Investigate the Effect of AB-101 in Breast Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Sexual Dysfunction", "Sexual Arousal Disorder", "Sexual Dysfunction, Physiological", "Breast Cancer", "Nipple Disorder", "Neuropathy", "Cancer of Breast" ], "interventions": [ { "name": "AB-101", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Applied Biology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "18 Years to 70 Years · Female only" }, "enrollment_count": 3, "start_date": "2018-07-09", "completion_date": "2019-10-12", "has_results": true, "last_update_posted_date": "2020-03-12", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03592121" }, { "nct_id": "NCT04831047", "title": "The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ptosis, Eyelid", "Conjunctiva Inflamed", "Eye Manifestations" ], "interventions": [ { "name": "Oxymetazoline hydrochloride 0.1% ophthalmic solution", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 114, "start_date": "2021-06-08", "completion_date": "2022-04-01", "has_results": true, "last_update_posted_date": "2023-04-24", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04831047" }, { "nct_id": "NCT03709927", "title": "4-way Crossover QT Evaluation in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiac Repolarization in Healthy Subjects" ], "interventions": [ { "name": "ZTI-01", "type": "DRUG" }, { "name": "Moxifloxacin 400mg", "type": "DRUG" }, { "name": "Placebo IV", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Nabriva Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 41, "start_date": "2018-01-11", "completion_date": "2018-08-21", "has_results": false, "last_update_posted_date": "2019-03-06", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03709927" }, { "nct_id": "NCT02726620", "title": "Decision Support for Intraoperative Low Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypotension" ], "interventions": [ { "name": "Attending real-time decision support", "type": "PROCEDURE" }, { "name": "In-room real-time decision support", "type": "PROCEDURE" }, { "name": "Attending feedback emails", "type": "PROCEDURE" }, { "name": "In-room provider feedback emails", "type": "PROCEDURE" }, { "name": "Anesthesia Information Management System (AIMS)", "type": "DEVICE" }, { "name": "Perioperative Data Warehouse (PDW)", "type": "DEVICE" }, { "name": "General anesthesia", "type": "PROCEDURE" }, { "name": "Pager system", "type": "DEVICE" }, { "name": "Central neuraxial anesthesia", "type": "PROCEDURE" }, { "name": "Non-cardiac surgery", "type": "PROCEDURE" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Sevoflurane", "type": "DRUG" }, { "name": "Desflurane", "type": "DRUG" }, { "name": "Isoflurane", "type": "DRUG" }, { "name": "Ephedrine", "type": "DRUG" }, { "name": "Phenylephrine", "type": "DRUG" }, { "name": "Norepinephrine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "Dobutamine", "type": "DRUG" }, { "name": "Dopamine", "type": "DRUG" }, { "name": "Isoproterenol", "type": "DRUG" }, { "name": "Milrinone", "type": "DRUG" }, { "name": "Atropine", "type": "DRUG" }, { "name": "Glycopyrrolate", "type": "DRUG" }, { "name": "Vasopressin", "type": "DRUG" }, { "name": "Terlipressin", "type": "DRUG" }, { "name": "Sodium Chloride 0.9%", "type": "DRUG" }, { "name": "Ringer's lactate", "type": "DRUG" }, { "name": "Hydroxyethyl starch solutions", "type": "DRUG" }, { "name": "Fresh Frozen Plasma", "type": "DRUG" }, { "name": "Packed Red Blood Cells", "type": "DRUG" }, { "name": "Albumin solutions", "type": "DRUG" }, { "name": "Plasma-Lyte", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Bupivacaine", "type": "DRUG" }, { "name": "Levobupivacaine", "type": "DRUG" }, { "name": "Ropivacaine", "type": "DRUG" }, { "name": "Mepivacaine", "type": "DRUG" }, { "name": "Tetracaine", "type": "DRUG" }, { "name": "Prilocaine", "type": "DRUG" }, { "name": "Procaine", "type": "DRUG" }, { "name": "Chloroprocaine", "type": "DRUG" }, { "name": "Benzocaine", "type": "DRUG" }, { "name": "Articaine", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "60 Years to 100 Years" }, "enrollment_count": 22435, "start_date": "2017-01-05", "completion_date": "2018-12-29", "has_results": true, "last_update_posted_date": "2019-05-16", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02726620" }, { "nct_id": "NCT02701582", "title": "Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Intracranial Aneurysm", "Brain Edema", "Scoliosis", "Surgery" ], "interventions": [ { "name": "Phenylephrine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "Albumin", "type": "OTHER" }, { "name": "Voluven", "type": "OTHER" }, { "name": "Normal Saline", "type": "OTHER" }, { "name": "Packed Red Blood Cells", "type": "OTHER" }, { "name": "FloTrac Monitor", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DEVICE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 66, "start_date": "2014-03", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2019-08-28", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02701582" }, { "nct_id": "NCT04898907", "title": "Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "ANG-3777 (Therapeutic Dose)", "type": "DRUG" }, { "name": "ANG-3777 (Supra-therapeutic Dose)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Angion Biomedica Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2021-06", "completion_date": "2021-09", "has_results": false, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04898907" }, { "nct_id": "NCT01848041", "title": "Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Blepharoptosis" ], "interventions": [ { "name": "RVL-1201", "type": "DRUG" }, { "name": "RVL-1201 Vehicle Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "RVL Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2013-05", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2021-11-26", "last_synced_at": "2026-09-06T10:27:32.330Z", "location_count": 1, "location_summary": "Morrow, Georgia", "locations": [ { "city": "Morrow", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01848041" } ] }